Researchers recruit killers to a tumor fight: Antibody immunotherapies developed to treat glioblastoma

Wednesday, April 16, 2025 | Steve Martin

 

Sandro Matosevic wearing gloves, goggles, and a white lab coat and conducting research in a laboratory setting.

Sandro Matosevic, a researcher in Purdue University’s College of Pharmacy, is working to treat glioblastoma, an incurable brain tumor, with antibody-based therapies that recruit immune cells and tether them to cancer cells. (Purdue University photo/Jennifer Stewart-Burton)

Recent Posts